Synthesis and Spectroscopic Analysis of S-Triazine-Linked Pyrazolone Derivatives
DOI:
https://doi.org/10.32628/IJSRCH251043Keywords:
Pyrazolone, Chalcone, Spectroscopy, Aldehydes, Cyanuric ChlorideAbstract
Pyrazolone is 5-membered heterocycle containing two adjacent nitrogen atoms. It can be viewed as a derivative of pyrazole possessing an additional carbonyl (C=O) group. Compounds containing this functional group are useful commercially in analgesics and dyes. Its play’s important role in drug discovery. Pyrazoles and pyrazolines present a wide range of biological activities. In the present study describe synthesis of various pyrazolones by reaction of N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl) acetamide with cyanuric chloride followed by reflux under ethanol using various aromatic aldehyde in the presence of alkali. All the synthesized compounds were characterized by 1HNMR, 13CNMR, IR, MASS spectroscopic techniques.
References
J. Syahri, E. Yuanita, B. A. Nurohmah, R. Armunanto, B. Purwono, Chalcone analogue as potent anti-malarial compounds against Plasmodium falciparum: Synthesis, biological evaluation, and docking simulation study. Asian Pac J Trop Biomed 7, 675–679 (2017).
M. A. Shalaby, S. A. Rizk, A. M. Fahim, Synthesis, reactions and application of chalcones: a systematic review. Org Biomol Chem 21, 5317–5346 (2023).
F. Pintus, M. J. Matos, S. Vilar, G. Hripcsak, C. Varela, E. Uriarte, L. Santana, F. Borges, R. Medda, A. Di Petrillo, B. Era, A. Fais, New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies. Bioorg Med Chem 25, 1687–1695 (2017).
S.G. Kucukguzel, S. Senkardes, Recent advances in bioactive pyrazoles, Eur. J. Med. Chem. 97 (2015) 786e815.
P.A. Lapchak, A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? Expert Opin. Pharmacother. 11 (2010) 1753e1763.
F. Meiattini, L. Prencipe, F. Bardelli, G. Giannini, P. Tarli, The 4- hydroxybenzoate/4-aminophenazone chromogenic system used in the enzymic determination of serum cholesterol, Clin. Chem. 24 (1978) 2161e2165.
J.B. Bussel, G. Cheng, M.N. Saleh, B. Psaila, L. Kovaleva, B. Meddeb, J. Kloczko, H. Hassani, B. Mayer, N.L. Stone, M. Arning, D. Provan, J.M. Jenkins, Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura, N. Engl. J. Med. 357 (2007) 2237e2247.
J.G. McHutchison, G. Dusheiko, M.L. Shiffman, M. Rodriguez-Torres, S. Sigal, M. Bourliere, T. Berg, S.C. Gordon, F.M. Campbell, D. Theodore, N. Blackman, J. Jenkins, N.H. Afdhal, T.P.L.S. Grp, Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C, N, Engl. J. Med. 357 (2007) 2227e2236.
F.G. Freitag, R. Cady, F. DiSerio, A. Elkind, R.M. Gallagher, J. Goldstein, J.A. Klapper, A.M. Rapoport, C. Sadowsky, J.R. Saper, T.R. Smith, Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine, Headache 41 (2001) 391e398.
G.L. Pecenco, A. Apollo, M. Bacciardi, Sulphenazone in pediatric practice, Case studies, Minerva Pediatr. 34 (1982) 39e43.
M. Himly, B. Jahn-Schmid, K. Pittertschatscher, B. Bohle, K. Grubmayr, F. Ferreira, H. Ebner, C. Ebner, IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone, J. Allergy Clin. Immunol. 111 (2003) 882e888.
F.D. Hart, P.L. Boardman, Trial of nifenazone ("THYLIN"), Br. Med. J. 1 (1964) 1553e1554.
